Business

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS. About Integra LifeScie

Integra Lifesciences Holdings CorporationJune 15, 20261
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

About this update from Integra Lifesciences Holdings Corporation

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under  EVENTS & PRESENTATIONS . About Integra LifeSciences Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com . Investor Relations: Chris Ward (609) 772-7736 [email protected] Media Contact: Laurene Isip (609) 208-8121 [email protected] Integra LifeSciences Holdings Corporation

View stock analysis, news, and events for Integra Lifesciences Holdings Corporation

Integra LifeSciencesTissue Reconstructionexecutive vice president

More from Integra Lifesciences Holdings Corporation

All Integra Lifesciences Holdings Corporation news →